Clinical Trials Directory

Trials / Completed

CompletedNCT02227836

Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis

Efficacy of Allergy Patch Testing in Directed Dietary Therapy of Eosinophilic Esophagitis: A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study is being done to see if allergy patch testing (APT) can help predict effective dietary therapy in patients with eosinophilic esophagitis.

Detailed description

Patients are referred to Mayo Clinic Rochester with an establish diagnosis of EoE and are nonresponsive to proton pump inhibitor (PPI) medical therapy. Eligible patients will then meet with one of three investigators complete the Mayo Dysphagia Questionaire-30 Day (MDQ-30) following which a standardized Allergy Patch testing (APT) will be conducted. Thereafter, a standard clinically indicated Six Food Elimination Diet treatment completed. Patients will follow up with one of three investigators following the elimination diet who will be blinded to the results of the APT. During this visit responders and nonresponders will be identified and nonresponders will complete a directed elimination diet based on APT results.

Conditions

Interventions

TypeNameDescription
DEVICEAllergy Patch Testing

Timeline

Start date
2014-08-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2014-08-28
Last updated
2019-04-17
Results posted
2019-04-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02227836. Inclusion in this directory is not an endorsement.